Clozapine, Ciprofloxacin and a Smoke-Free Ward

This looks like clozapine toxicity from a rising plasma level, not a relapse and not 'settling'.

Mechanism 1 - smoking cessation. Tobacco smoke (the polycyclic aromatic hydrocarbons, not the nicotine) induces CYP1A2, which metabolises clozapine. Remove the smoke and induction falls away over roughly a week, so the same 400 mg produces a substantially higher level. Nicotine replacement does not replace this effect - that is the common error.

Mechanism 2 - ciprofloxacin. A potent CYP1A2 inhibitor added two days ago. Two mechanisms pushing the same direction at once.

The clinical picture fits: drowsiness, drooling, confusion, tachycardia, low-normal BP - anticholinergic and noradrenergic toxicity. Two things must be actively excluded: constipation/ileus (clozapine's most lethal adverse effect and a classic cause of a sudden level rise) and sepsis from the UTI - temp 37.6 and tachycardia could be either.

Why the normal ANC matters: it makes agranulocytosis unlikely as the explanation, so it doesn't distract from the actual problem, and it means the current deterioration is not a reason to stop clozapine permanently. It does not, however, rule out a bowel obstruction or infection.

'Settled, sleeping well' was the warning sign, not the reassurance.

I do not wait two hours, and I do not simply 'monitor'.

• Airway and safety: drowsy and drooling is an aspiration risk. Lateral position, suction available, continuous observation, no food or oral medication until reviewed.
• Vitals and escalation: full observations, ECG for QTc and tachycardia, capillary glucose, repeat temperature. This patient meets escalation criteria - I use the early warning score and call the on-call psychiatric doctor and the medical team covering for the registrar, and I document the time of each call and the response. 'The registrar is in theatre' is a reason to find another doctor, not a reason to wait.
• Hold the clozapine and put the next doses on hold with the reason written; I would not administer another 400 mg to a drooling, disoriented man. I would also flag the ciprofloxacin.
• Request a clozapine level, FBC, U&E, CRP, and abdominal assessment; check the bowel chart in detail - when did he last open his bowels, is the abdomen distended, is he passing wind?
• Hydration and falls precautions; increased supervision.

Communication: inform the nurse in charge and document the reasoning, including that smoking cessation plus ciprofloxacin is the likely cause. If I cannot get a medical review within the hour, I escalate to the site coordinator or on-call consultant.

Get the smoking status right, in writing, because it will move again.

• If he stays abstinent: he may need a lower maintenance dose than before, with a level rechecked once he is steady. Discharge on 400 mg with no plan is setting up a repeat.
• If he resumes 25 a day: induction returns over days to weeks and his level will fall - the risk flips from toxicity to relapse, and the dose may need to rise again. Both directions are dangerous; the safe rule is that any change in smoking gets a level and a review.
• NRT is not a substitute for the interaction and should not be presented as one.
• Ciprofloxacin should be flagged as a drug to avoid or to pair with level monitoring in future.
• What he needs to know himself: 'If you stop or start smoking, tell your doctor before anything else changes.' Written, in plain language, with the prescriber's number.

GP handover should state: clozapine dose and level, the admission toxicity, the two interacting mechanisms by name, the smoking plan, the monitoring schedule (level, FBC, and the bowel/diabetes checks), and the specific instruction to recheck the level after any change in smoking or any new antibiotic. Also flag who to call if he becomes drowsy or confused again - unplanned, this looks exactly like a relapse and gets treated with more antipsychotic.